Copay Assistance – Good For Patients, Bad For Prices
Peter Bach and I have an essay in the Annals of Internal Medicine laying out some of the problems with pharmaceutical funded copay assistance programs. Check it out.
Similar Posts
Making Mammograms Automatic – Unintended Consequences Of A Behavioral Economic Intervention
The experiment was simple. A group of behaviorally-minded researchers tested whether patients are more likely to receive mammograms when those tests are automatically scheduled (meaning they can opt out if they want) versus when they have to opt in for the tests. Automatic scheduling should have increased mammograms. It didn’t. In one respect, it even…
